HPV cervical CA screening cuts odds of later CIN3+ diagnosis – Medical Xpress


Medical Xpress

HPV cervical CA screening cuts odds of later CIN3+ diagnosis
Medical Xpress
(HealthDay)—The use of primary human papillomavirus (HPV) testing versus cytology results in reduced likelihood of cervical intraepithelial neoplasia (CIN) grade 3 or worse (CIN3+) at 48 months, according to a study published in the July 3 issue of
For Women Over 30, There May Be A Better Choice Than The Pap SmearNPR
HPV test is better than Pap smear at detecting precancerous cervical changes, study saysWashington Post
HPV test should replace Pap test for cervical cancer screening, study suggestsCBC.ca
CNN –ABC News –WebMD –NBCNews.com
all 52 news articles »

Comments

comments

You must be logged in to post a comment Login